- Telehealth Visits
- Insurance plan information
Jessica Jimenez, MD, PhD
She | Her | HersNeurology • Sleep Medicine- Telehealth Visits
- Insurance plan information
General Neurology Mission Bay
Jessica Jimenez, MD, PhD
She | Her | HersNeurology • Sleep MedicineGeneral Neurology Mission Bay
- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jessica Jimenez is a neurologist who specializes in sleep medicine. In addition to caring for patients with sleep disorders, she has expertise in addressing a broad range of neurological concerns.
In her research, Jimenez focuses on understanding factors that create the brain's drive to sleep and how they impact wellness and disease.
Jimenez earned her medical degree and doctorate at Columbia University. At UCSF, she completed a residency in neurology and a fellowship in sleep medicine.
Education & training
Board certification
- Neurology, American Board of Neurological Surgery
- Behavioral Sleep Medicine, American Board of Neurological Surgery
Residency
- Neurology, UCSF Graduate Medical Education
Degree
- MD, Columbia University College of Physicians and Surgeons
My expertise
Locations
My research
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.